financetom
Business
financetom
/
Business
/
AstraZeneca to buy Amolyt Pharma for $1.05 billion to boost rare diseases portfolio
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AstraZeneca to buy Amolyt Pharma for $1.05 billion to boost rare diseases portfolio
Mar 14, 2024 12:44 AM

(Reuters) - Drugmaker AstraZeneca said on Thursday it will acquire rare endocrine diseases-focused firm Amolyt Pharma for $1.05 billion in cash, in a bid to boost its rare diseases portfolio.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved